Cargando…
Does older age justify chlorambucil control arms for chronic lymphocytic leukemia clinical trials: a SEER-Medicare analysis
Autores principales: | Diamond, Akiva, Vu, Long, Bensken, Wyatt P., Koroukian, Siran M., Caimi, Paolo F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317827/ https://www.ncbi.nlm.nih.gov/pubmed/37221284 http://dx.doi.org/10.1038/s41375-023-01915-y |
Ejemplares similares
-
Ibrutinib Is Associated With Increased Cardiovascular Events and Major Bleeding in Older CLL Patients
por: Diamond, Akiva, et al.
Publicado: (2023) -
State Voting Patterns in the 2016 Presidential Election and Uninsured Rates in Non-elderly Adults
por: Kim, Uriel, et al.
Publicado: (2020) -
Treatment practice in the elderly patient with chronic lymphocytic leukemia—analysis of the combined SEER and Medicare database
por: Satram-Hoang, Sacha, et al.
Publicado: (2014) -
Rapidly progressive renal failure due to chronic lymphocytic leukemia - Response to chlorambucil
por: Junglee, N. A., et al.
Publicado: (2012) -
Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study
por: Fresa, Alberto, et al.
Publicado: (2022)